Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIVA KIDS vs Fuji IX EXTRA in Primary Molars
NCT03788616Phase 3Completed
- Start
- Nov 2018
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial (2 arms). Primary endpoint: Success Rate of ACTIVA BIOACTIVE and Fuji IX Extra GIC With ART in Class I Carious Cavity of Primary Teeth at 12 months. Started Nov 2018; status: completed.
Beyond the preview
Go deeper on NCT03788616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03788616.